Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2014

01-05-2014 | Review

Implications of adiponectin in linking metabolism to testicular function

Author: Luc J. Martin

Published in: Endocrine | Issue 1/2014

Login to get access

Abstract

Obesity is a major health problem, contributing to the development of various diseases with aging. In humans, obesity has been associated with reduced testosterone production and subfertility. Adipose tissue is an important source of hormones having influences on both metabolism and reproduction. Among them, the production and secretion of adiponectin is inversely correlated to the severity of obesity. The purpose of this review of literature is to present the current state of knowledge on adiponectin research to determine whether this hormone affects reproduction in men. Surprisingly, evidences show negative influences of adiponectin on GnRH secretion from the hypothalamus, LH and FSH secretion from the pituitary and testosterone at the testicular level. Thus far, the involvement of adiponectin in the influence of metabolism on reproduction in men is limited. However, adiponectin and its receptors are expressed by different cell types of the male gonad, including Leydig cells, spermatozoa, and epididymis. In addition, actions of adiponectin at the testicular level have been shown to promote spermatogenesis and sperm maturation. Therefore, autocrine/paracrine actions of adiponectin in the testis may contribute to support male reproductive function.
Literature
1.
F.X. Pi-Sunyer, The obesity epidemic: pathophysiology and consequences of obesity. Obes. Res. 10(Suppl 2), 97S–104S (2002)PubMed
2.
K.M. Flegal, M.D. Carroll, B.K. Kit, C.L. Ogden, Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. J. Am. Med. Assoc. 307, 491–497 (2012)
3.
C.A. Derby, S. Zilber, D. Brambilla, K.H. Morales, J.B. McKinlay, Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin. Endocrinol. (Oxf.) 65, 125–131 (2006)
4.
R.S. Tan, S.J. Pu, Impact of obesity on hypogonadism in the andropause. Int. J. Androl. 25, 195–201 (2002)PubMed
5.
P.M. Mah, G.A. Wittert, Obesity and testicular function. Mol. Cell. Endocrinol. 316, 180–186 (2010)PubMed
6.
D. Landry, F. Cloutier, L.J. Martin, Implications of leptin in neuroendocrine regulation of male reproduction. Reprod. Biol. 13, 1–14 (2013)PubMed
7.
M. Pardo, A. Roca-Rivada, L.M. Seoane, F.F. Casanueva, Obesidomics: contribution of adipose tissue secretome analysis to obesity research. Endocrine 41, 374–383 (2012)PubMed
8.
K. Marinou, D. Tousoulis, A.S. Antonopoulos, E. Stefanadi, C. Stefanadis, Obesity and cardiovascular disease: from pathophysiology to risk stratification. Int. J. Cardiol. 138, 3–8 (2010)PubMed
9.
K. Rabe, M. Lehrke, K.G. Parhofer, U.C. Broedl, Adipokines and insulin resistance. Mol. Med. Camb. Mass. 14, 741–751 (2008)PubMedCentralPubMed
10.
P.G. Cohen, Aromatase, adiposity, aging and disease. The hypogonadal–metabolic–atherogenic-disease and aging connection. Med. Hypotheses 56, 702–708 (2001)PubMed
11.
A. Vermeulen, Decreased androgen levels and obesity in men. Ann. Med. 28, 13–15 (1996)PubMed
12.
A. Vermeulen, J.M. Kaufman, Ageing of the hypothalamo–pituitary–testicular axis in men. Horm. Res. 43, 25–28 (1995)PubMed
13.
G. Schneider, M.A. Kirschner, R. Berkowitz, N.H. Ertel, Increased estrogen production in obese men. J. Clin. Endocrinol. Metab. 48, 633–638 (1979)PubMed
14.
A.M. Corbould, S.J. Judd, R.J. Rodgers, Expression of types 1, 2, and 3 17 beta-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women. J. Clin. Endocrinol. Metab. 83, 187–194 (1998)PubMed
15.
P. Mårin, S. Arver, Androgens and abdominal obesity. Baillières Clin. Endocrinol. Metab. 12, 441–451 (1998)PubMed
16.
P. Mårin, Testosterone and regional fat distribution. Obes. Res. 3(Suppl 4), 609S–612S (1995)PubMed
17.
R. Lazarus, D. Sparrow, S. Weiss, Temporal relations between obesity and insulin: longitudinal data from the normative aging study. Am. J. Epidemiol. 147, 173–179 (1998)PubMed
18.
D. Goodman-Gruen, E. Barrett-Connor, Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 23, 912–918 (2000)PubMed
19.
E.C. Tsai, E.J. Boyko, D.L. Leonetti, W.Y. Fujimoto, Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. Int. J. Obes. Relat. Metab. Disord. 24, 485–491 (2000)PubMed
20.
V.A. Giagulli, J.M. Kaufman, A. Vermeulen, Pathogenesis of the decreased androgen levels in obese men. J. Clin. Endocrinol. Metab. 79, 997–1000 (1994)PubMed
21.
P.G. Cohen, The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone–estradiol shunt: a major factor in the genesis of morbid obesity. Med. Hypotheses 52, 49–51 (1999)PubMed
22.
H.K. Kley, H.G. Solbach, J.C. McKinnan, H.L. Krüskemper, Testosterone decrease and oestrogen increase in male patients with obesity. Acta Endocrinol. (Cph.) 91, 553–563 (1979)
23.
B. Zumoff, G.W. Strain, L.K. Miller, W. Rosner, R. Senie, D.S. Seres, R.S. Rosenfeld, Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J. Clin. Endocrinol. Metab. 71, 929–931 (1990)PubMed
24.
T. Kadowaki, T. Yamauchi, Adiponectin and adiponectin receptors. Endocr. Rev. 26, 439–451 (2005)PubMed
25.
J. Hoffstedt, E. Arvidsson, E. Sjölin, K. Wåhlén, P. Arner, Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J. Clin. Endocrinol. Metab. 89, 1391–1396 (2004)PubMed
26.
K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, Y. Okamoto, H. Iwahashi, H. Kuriyama, N. Ouchi, K. Maeda, M. Nishida, S. Kihara, N. Sakai, T. Nakajima, K. Hasegawa, M. Muraguchi, Y. Ohmoto, T. Nakamura, S. Yamashita, T. Hanafusa, Y. Matsuzawa, Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20, 1595–1599 (2000)PubMed
27.
I.J. Neeland, C.R. Ayers, A.K. Rohatgi, A.T. Turer, J.D. Berry, S.R. Das, G.L. Vega, A. Khera, D.K. McGuire, S.M. Grundy, J.A. de Lemos, Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obes. Silver Spring Md. 21, E439–E447 (2013)
28.
Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, H. Kuriyama, M. Nishida, S. Yamashita, K. Okubo, K. Matsubara, M. Muraguchi, Y. Ohmoto, T. Funahashi, Y. Matsuzawa, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79–83 (1999)PubMed
29.
M. Cnop, P.J. Havel, K.M. Utzschneider, D.B. Carr, M.K. Sinha, E.J. Boyko, B.M. Retzlaff, R.H. Knopp, J.D. Brunzell, S.E. Kahn, Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46, 459–469 (2003)PubMed
30.
F.B. Diamond Jr, D. Cuthbertson, S. Hanna, D. Eichler, Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J. Pediatr. Endocrinol. Metab. 17, 1069–1075 (2004)PubMed
31.
M. Bulló, J. Salas-Salvadó, P. García-Lorda, Adiponectin expression and adipose tissue lipolytic activity in lean and obese women. Obes. Surg. 15, 382–386 (2005)PubMed
32.
S.K. Jacobi, K.M. Ajuwon, T.E. Weber, J.L. Kuske, C.J. Dyer, M.E. Spurlock, Cloning and expression of porcine adiponectin, and its relationship to adiposity, lipogenesis and the acute phase response. J. Endocrinol. 182, 133–144 (2004)PubMed
33.
T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, O. Ezaki, Y. Akanuma, O. Gavrilova, C. Vinson, M.L. Reitman, H. Kagechika, K. Shudo, M. Yoda, Y. Nakano, K. Tobe, R. Nagai, S. Kimura, M. Tomita, P. Froguel, T. Kadowaki, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941–946 (2001)PubMed
34.
E. Hu, P. Liang, B.M. Spiegelman, AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697–10703 (1996)PubMed
35.
Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K.: Adiponectin and adiponectin receptors in obesity-linked insulin resistance. Novartis Found. Symp. 286, 164–176 (2007); discussion 176–182, 200–203
36.
C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, P.A. Tataranni, Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930–1935 (2001)PubMed
37.
B. Antuna-Puente, B. Feve, S. Fellahi, J.-P. Bastard, Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 34, 2–11 (2008)PubMed
38.
L. Sieminska, B. Marek, B. Kos-Kudla, D. Niedziolka, D. Kajdaniuk, M. Nowak, J. Glogowska-Szelag, Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters. J. Endocrinol. Invest. 27, 528–534 (2004)PubMed
39.
Y. Okamoto, Adiponectin provides cardiovascular protection in metabolic syndrome. Cardiol. Res. Pract. 2011, 313179 (2011)PubMedCentralPubMed
40.
H.-S. Kim, J. Jo, J.E. Lim, Y.D. Yun, S.J. Baek, T.-Y. Lee, K.B. Huh, S.H. Jee, Adiponectin as predictor for diabetes among pre-diabetic groups. Endocrine 44, 411–418 (2013)PubMed
41.
J. Bai, Y. Liu, G.-F. Niu, L.-X. Bai, X.-Y. Xu, G.-Z. Zhang, L.-X. Wang, Relationship between adiponectin and testosterone in patients with type 2 diabetes. Biochem. Medica Časopis Hrvat. Društva Med. Biokem. HDMB 21, 65–70 (2011)
42.
P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, H.F. Lodish, A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746–26749 (1995)PubMed
43.
L. Shapiro, P.E. Scherer, The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol. 8, 335–338 (1998)PubMed
44.
Y. Wang, K.S.L. Lam, M. Yau, A. Xu, Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem. J. 409, 623–633 (2008)PubMed
45.
F. Simpson, J.P. Whitehead, Adiponectin: it’s all about the modifications. Int. J. Biochem. Cell Biol. 42, 785–788 (2010)PubMed
46.
Y. Wang, A. Xu, C. Knight, L.Y. Xu, G.J.S. Cooper, Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J. Biol. Chem. 277, 19521–19529 (2002)PubMed
47.
Y. Wang, K.S.L. Lam, L. Chan, K.W. Chan, J.B.B. Lam, M.C. Lam, R.C.L. Hoo, W.W.N. Mak, G.J.S. Cooper, A. Xu, Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J. Biol. Chem. 281, 16391–16400 (2006)PubMed
48.
A.A. Richards, T. Stephens, H.K. Charlton, A. Jones, G.A. Macdonald, J.B. Prins, J.P. Whitehead, Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications. Mol. Endocrinol. Baltim. Md. 20, 1673–1687 (2006)
49.
T.-S. Tsao, E. Tomas, H.E. Murrey, C. Hug, D.H. Lee, N.B. Ruderman, J.E. Heuser, H.F. Lodish, Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J. Biol. Chem. 278, 50810–50817 (2003)PubMed
50.
R. Basu, U.B. Pajvani, R.A. Rizza, P.E. Scherer, Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 56, 2174–2177 (2007)PubMed
51.
U.B. Pajvani, M. Hawkins, T.P. Combs, M.W. Rajala, T. Doebber, J.P. Berger, J.A. Wagner, M. Wu, A. Knopps, A.H. Xiang, K.M. Utzschneider, S.E. Kahn, J.M. Olefsky, T.A. Buchanan, P.E. Scherer, Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 279, 12152–12162 (2004)PubMed
52.
H. Waki, T. Yamauchi, J. Kamon, Y. Ito, S. Uchida, S. Kita, K. Hara, Y. Hada, F. Vasseur, P. Froguel, S. Kimura, R. Nagai, T. Kadowaki, Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J. Biol. Chem. 278, 40352–40363 (2003)PubMed
53.
R.B. Ceddia, R. Somwar, A. Maida, X. Fang, G. Bikopoulos, G. Sweeney, Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 48, 132–139 (2005)PubMed
54.
X. Fang, R. Palanivel, X. Zhou, Y. Liu, A. Xu, Y. Wang, G. Sweeney, Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts. J. Mol. Endocrinol. 35, 465–476 (2005)PubMed
55.
E. Tomas, T.-S. Tsao, A.K. Saha, H.E. Murrey, Cc. Zhang, C. cheng, S.I. Itani, H.F. Lodish, N.B. Ruderman, Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl Acad. Sci. USA 99, 16309–16313 (2002)PubMedCentralPubMed
56.
J. Fruebis, T.S. Tsao, S. Javorschi, D. Ebbets-Reed, M.R. Erickson, F.T. Yen, B.E. Bihain, H.F. Lodish, Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl Acad. Sci. USA 98, 2005–2010 (2001)PubMedCentralPubMed
57.
U.B. Pajvani, X. Du, T.P. Combs, A.H. Berg, M.W. Rajala, T. Schulthess, J. Engel, M. Brownlee, P.E. Scherer, Structure–function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J. Biol. Chem. 278, 9073–9085 (2003)PubMed
58.
H. Waki, T. Yamauchi, J. Kamon, S. Kita, Y. Ito, Y. Hada, S. Uchida, A. Tsuchida, S. Takekawa, T. Kadowaki, Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146, 790–796 (2005)PubMed
59.
C. Chabrolle, L. Tosca, J. Dupont, Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis. Reprod. Camb. Engl. 133, 719–731 (2007)
60.
Z.V. Wang, P.E. Scherer, Adiponectin, cardiovascular function, and hypertension. Hypertension 51, 8–14 (2008)PubMed
61.
Luque-Ramírez, M., Martínez-García, M.Á., Montes-Nieto, R., Fernández-Durán, E., Insenser, M., Alpañés, M., Escobar-Morreale, H.F.: Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Hum. Reprod. Oxf. Engl. 28, 1908–1918 (2013)
62.
T.P. Combs, A.H. Berg, M.W. Rajala, S. Klebanov, P. Iyengar, J.C. Jimenez-Chillaron, M.E. Patti, S.L. Klein, R.S. Weinstein, P.E. Scherer, Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52, 268–276 (2003)PubMed
63.
K. Robinson, J. Prins, B. Venkatesh, Clinical review: adiponectin biology and its role in inflammation and critical illness. Crit. Care Lond. Engl. 15, 221 (2011)
64.
K. Brochu-Gaudreau, C. Rehfeldt, R. Blouin, V. Bordignon, B.D. Murphy, M.-F. Palin, Adiponectin action from head to toe. Endocrine 37, 11–32 (2010)PubMed
65.
M. Calvani, A. Scarfone, L. Granato, E.V. Mora, G. Nanni, M. Castagneto, A.V. Greco, M. Manco, G. Mingrone, Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes 53, 939–947 (2004)PubMed
66.
L. Fajas, J.C. Fruchart, J. Auwerx, Transcriptional control of adipogenesis. Curr. Opin. Cell Biol. 10, 165–173 (1998)PubMed
67.
T.F. Osborne, Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 275, 32379–32382 (2000)PubMed
68.
M.I. Yilmaz, A. Sonmez, K. Caglar, D.E. Gok, T. Eyileten, M. Yenicesu, C. Acikel, N. Bingol, S. Kilic, Y. Oguz, A. Vural, Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria. Endocrine 25, 207–214 (2004)PubMed
69.
A.C. Doran, N. Meller, A. Cutchins, H. Deliri, R.P. Slayton, S.N. Oldham, J.B. Kim, S.R. Keller, C.A. McNamara, The helix–loop–helix factors Id3 and E47 are novel regulators of adiponectin. Circ. Res. 103, 624–634 (2008)PubMedCentralPubMed
70.
N. Maeda, M. Takahashi, T. Funahashi, S. Kihara, H. Nishizawa, K. Kishida, H. Nagaretani, M. Matsuda, R. Komuro, N. Ouchi, H. Kuriyama, K. Hotta, T. Nakamura, I. Shimomura, Y. Matsuzawa, PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094–2099 (2001)PubMed
71.
M. Iwaki, M. Matsuda, N. Maeda, T. Funahashi, Y. Matsuzawa, M. Makishima, I. Shimomura, Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52, 1655–1663 (2003)PubMed
72.
K. Thomas, D.-Y. Sung, X. Chen, W. Thompson, Y.E. Chen, J. McCarrey, W. Walker, M. Griswold, Developmental patterns of PPAR and RXR gene expression during spermatogenesis. Front. Biosci. Elite Ed. 3, 1209–1220 (2011)PubMed
73.
M.P. Kowalewski, M.T. Dyson, P.R. Manna, D.M. Stocco, Involvement of peroxisome proliferator-activated receptor gamma in gonadal steroidogenesis and steroidogenic acute regulatory protein expression. Reprod. Fertil. Dev. 21, 909–922 (2009)PubMed
74.
B. El-Asmar, X.C. Giner, J.J. Tremblay, Transcriptional cooperation between NF-kappaB p50 and CCAAT/enhancer binding protein beta regulates Nur77 transcription in Leydig cells. J. Mol. Endocrinol. 42, 131–138 (2009)PubMed
75.
L.M. Grønning, M.K. Dahle, K.A. Taskén, S. Enerbäck, L. Hedin, K. Taskén, H.K. Knutsen, Isoform-specific regulation of the CCAAT/enhancer-binding protein family of transcription factors by 3′,5′-cyclic adenosine monophosphate in Sertoli cells. Endocrinology 140, 835–843 (1999)PubMed
76.
H. Wang, F. Liu, C.F. Millette, D.L. Kilpatrick, Expression of a novel, sterol-insensitive form of sterol regulatory element binding protein 2 (SREBP2) in male germ cells suggests important cell- and stage-specific functions for SREBP targets during spermatogenesis. Mol. Cell. Biol. 22, 8478–8490 (2002)PubMedCentralPubMed
77.
M. Carroll, B. Robaire, Null mutation of the transcription factor inhibitor of DNA binding 3 (ID3) in male mice adversely impacts on fertility and reproductive outcome. J. Androl. 33, 667–674 (2012)PubMed
78.
J. Chaudhary, J. Johnson, G. Kim, M.K. Skinner, Hormonal regulation and differential actions of the helix–loop–helix transcriptional inhibitors of differentiation (Id1, Id2, Id3, and Id4) in Sertoli cells. Endocrinology 142, 1727–1736 (2001)PubMed
79.
J. Chaudhary, M.K. Skinner, The basic helix–loop–helix E2A gene product E47, not E12, is present in differentiating Sertoli cells. Mol. Reprod. Dev. 52, 1–8 (1999)
80.
T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, T. Kadowaki, Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762–769 (2003)PubMed
81.
T. Yamauchi, Y. Nio, T. Maki, M. Kobayashi, T. Takazawa, M. Iwabu, M. Okada-Iwabu, S. Kawamoto, N. Kubota, T. Kubota, Y. Ito, J. Kamon, A. Tsuchida, K. Kumagai, H. Kozono, Y. Hada, H. Ogata, K. Tokuyama, M. Tsunoda, T. Ide, K. Murakami, M. Awazawa, I. Takamoto, P. Froguel, K. Hara, K. Tobe, R. Nagai, K. Ueki, T. Kadowaki, Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13, 332–339 (2007)PubMed
82.
M. Bjursell, A. Ahnmark, M. Bohlooly-Y, L. William-Olsson, M. Rhedin, X.-R. Peng, K. Ploj, A.-K. Gerdin, G. Arnerup, A. Elmgren, A.-L. Berg, J. Oscarsson, D. Lindén, Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 56, 583–593 (2007)PubMed
83.
K. Kos, A.L. Harte, N.F. da Silva, A. Tonchev, G. Chaldakov, S. James, D.R. Snead, B. Hoggart, J.P. O’Hare, P.G. McTernan, S. Kumar, Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J. Clin. Endocrinol. Metab. 92, 1129–1136 (2007)PubMed
84.
F. Rodriguez-Pacheco, A.J. Martinez-Fuentes, S. Tovar, L. Pinilla, M. Tena-Sempere, C. Dieguez, J.P. Castaño, M.M. Malagon, Regulation of pituitary cell function by adiponectin. Endocrinology 148, 401–410 (2007)PubMed
85.
J.E. Caminos, R. Nogueiras, F. Gaytán, R. Pineda, C.R. González, M.L. Barreiro, J.P. Castaño, M.M. Malagón, L. Pinilla, J. Toppari, C. Diéguez, M. Tena-Sempere, Novel expression and direct effects of adiponectin in the rat testis. Endocrinology 149, 3390–3402 (2008)PubMed
86.
E. Lord, S. Ledoux, B.D. Murphy, D. Beaudry, M.F. Palin, Expression of adiponectin and its receptors in swine. J. Anim. Sci. 83, 565–578 (2005)PubMed
87.
S. Ledoux, D.B. Campos, F.L. Lopes, M. Dobias-Goff, M.-F. Palin, B.D. Murphy, Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology 147, 5178–5186 (2006)PubMed
88.
R. Ramachandran, O.M. Ocón-Grove, S.L. Metzger, Molecular cloning and tissue expression of chicken AdipoR1 and AdipoR2 complementary deoxyribonucleic acids. Domest. Anim. Endocrinol. 33, 19–31 (2007)PubMed
89.
C. Chabrolle, L. Tosca, S. Crochet, S. Tesseraud, J. Dupont, Expression of adiponectin and its receptors (AdipoR1 and AdipoR2) in chicken ovary: potential role in ovarian steroidogenesis. Domest. Anim. Endocrinol. 33, 480–487 (2007)PubMed
90.
A.E. Civitarese, C.P. Jenkinson, D. Richardson, M. Bajaj, K. Cusi, S. Kashyap, R. Berria, R. Belfort, R.A. DeFronzo, L.J. Mandarino, E. Ravussin, Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia 47, 816–820 (2004)PubMed
91.
C. Hug, J. Wang, N.S. Ahmad, J.S. Bogan, T.-S. Tsao, H.F. Lodish, T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc. Natl Acad. Sci. USA 101, 10308–10313 (2004)PubMedCentralPubMed
92.
K. Asada, H. Yoshiji, R. Noguchi, Y. Ikenaka, M. Kitade, K. Kaji, J. Yoshii, K. Yanase, T. Namisaki, M. Yamazaki, T. Tsujimoto, T. Akahane, M. Uemura, H. Fukui, Crosstalk between high-molecular-weight adiponectin and T-cadherin during liver fibrosis development in rats. Int. J. Mol. Med. 20, 725–729 (2007)PubMed
93.
M.S. Denzel, M.-C. Scimia, P.M. Zumstein, K. Walsh, P. Ruiz-Lozano, B. Ranscht, T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J. Clin. Invest. 120, 4342–4352 (2010)PubMedCentralPubMed
94.
T. Takeuchi, Y. Adachi, Y. Ohtsuki, M. Furihata, Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med. Mol. Morphol. 40, 115–120 (2007)PubMed
95.
A.V. Andreeva, J. Han, M.A. Kutuzov, J. Profirovic, V.A. Tkachuk, T.A. Voyno-Yasenetskaya, T-cadherin modulates endothelial barrier function. J. Cell. Physiol. 223, 94–102 (2010)PubMed
96.
S.B. Munro, O.W. Blaschuk, A comprehensive survey of the cadherins expressed in the testes of fetal, immature, and adult mice utilizing the polymerase chain reaction. Biol. Reprod. 55, 822–827 (1996)PubMed
97.
X. Mao, C.K. Kikani, R.A. Riojas, P. Langlais, L. Wang, F.J. Ramos, Q. Fang, C.Y. Christ-Roberts, J.Y. Hong, R.-Y. Kim, F. Liu, L.Q. Dong, APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell Biol. 8, 516–523 (2006)PubMed
98.
M.J. Yoon, G.Y. Lee, J–.J. Chung, Y.H. Ahn, S.H. Hong, J.B. Kim, Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55, 2562–2570 (2006)PubMed
99.
T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, T. Kadowaki, Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288–1295 (2002)PubMed
100.
Y. Li, D.H. Ramdhan, H. Naito, N. Yamagishi, Y. Ito, Y. Hayashi, Y. Yanagiba, A. Okamura, H. Tamada, F.J. Gonzalez, T. Nakajima, Ammonium perfluorooctanoate may cause testosterone reduction by adversely affecting testis in relation to PPARα. Toxicol. Lett. 205, 265–272 (2011)PubMed
101.
L. Brion, P.M. Maloberti, N.V. Gomez, C. Poderoso, A.B. Gorostizaga, M.M.M.S. Garcia, A.B. Acquier, M. Cooke, C.F. Mendez, E.J. Podesta, C. Paz, MAPK phosphatase-1 (MKP-1) expression is up-regulated by hCG/cAMP and modulates steroidogenesis in MA-10 Leydig cells. Endocrinology 152, 2665–2677 (2011)PubMed
102.
S.W. Ahn, G.-T. Gang, S. Tadi, B. Nedumaran, Y.D. Kim, J.H. Park, G.R. Kweon, S.-H. Koo, K. Lee, R.-S. Ahn, Y.-H. Yim, C.-H. Lee, R.A. Harris, H.-S. Choi, Phosphoenolpyruvate carboxykinase and glucose-6-phosphatase are required for steroidogenesis in testicular Leydig cells. J. Biol. Chem. 287, 41875–41887 (2012)PubMedCentralPubMed
103.
L. Tosca, C. Chabrolle, J. Dupont, AMPK: a link between metabolism and reproduction? Médecine Sci. 24, 297–300 (2008)
104.
L. Tosca, P. Froment, P. Solnais, P. Ferré, F. Foufelle, J. Dupont, Adenosine 5′-monophosphate-activated protein kinase regulates progesterone secretion in rat granulosa cells. Endocrinology 146, 4500–4513 (2005)PubMed
105.
L. Tosca, C. Chabrolle, S. Uzbekova, J. Dupont, Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine 5′ monophosphate-activated protein kinase (AMPK). Biol. Reprod. 76, 368–378 (2007)PubMed
106.
R. Ouedraogo, X. Wu, S.-Q. Xu, L. Fuchsel, H. Motoshima, K. Mahadev, K. Hough, R. Scalia, B.J. Goldstein, Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 55, 1840–1846 (2006)PubMed
107.
P. Park, H. Huang, M.R. McMullen, K. Bryan, L.E. Nagy, Activation of cyclic-AMP response element binding protein contributes to adiponectin-stimulated interleukin-10 expression in RAW 264.7 macrophages. J. Leukoc. Biol. 83, 1258–1266 (2008)PubMed
108.
J.-P. Wen, W.-S. Lv, J. Yang, A.-F. Nie, X.-B. Cheng, Y. Yang, Y. Ge, X.-Y. Li, G. Ning, Globular adiponectin inhibits GnRH secretion from GT1-7 hypothalamic GnRH neurons by induction of hyperpolarization of membrane potential. Biochem. Biophys. Res. Commun. 371, 756–761 (2008)PubMed
109.
N. Kubota, W. Yano, T. Kubota, T. Yamauchi, S. Itoh, H. Kumagai, H. Kozono, I. Takamoto, S. Okamoto, T. Shiuchi, R. Suzuki, H. Satoh, A. Tsuchida, M. Moroi, K. Sugi, T. Noda, H. Ebinuma, Y. Ueta, T. Kondo, E. Araki, O. Ezaki, R. Nagai, K. Tobe, Y. Terauchi, K. Ueki, Y. Minokoshi, T. Kadowaki, Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 6, 55–68 (2007)PubMed
110.
A. Psilopanagioti, H. Papadaki, E.F. Kranioti, T.K. Alexandrides, J.N. Varakis, Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology 89, 38–47 (2009)PubMed
111.
M. Mitchell, D.T. Armstrong, R.L. Robker, R.J. Norman, Adipokines: implications for female fertility and obesity. Reprod. Camb. Engl. 130, 583–597 (2005)
112.
T.P. Combs, U.B. Pajvani, A.H. Berg, Y. Lin, L.A. Jelicks, M. Laplante, A.R. Nawrocki, M.W. Rajala, A.F. Parlow, L. Cheeseboro, Y–.Y. Ding, R.G. Russell, D. Lindemann, A. Hartley, G.R.C. Baker, S. Obici, Y. Deshaies, M. Ludgate, L. Rossetti, P.E. Scherer, A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145, 367–383 (2004)PubMed
113.
N. Kubota, Y. Terauchi, T. Yamauchi, T. Kubota, M. Moroi, J. Matsui, K. Eto, T. Yamashita, J. Kamon, H. Satoh, W. Yano, P. Froguel, R. Nagai, S. Kimura, T. Kadowaki, T. Noda, Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277, 25863–25866 (2002)PubMed
114.
K. Ma, A. Cabrero, P.K. Saha, H. Kojima, L. Li, B.H.-J. Chang, A. Paul, L. Chan, Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J. Biol. Chem. 277, 34658–34661 (2002)PubMed
115.
N. Maeda, I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, H. Nagaretani, N. Furuyama, H. Kondo, M. Takahashi, Y. Arita, R. Komuro, N. Ouchi, S. Kihara, Y. Tochino, K. Okutomi, M. Horie, S. Takeda, T. Aoyama, T. Funahashi, Y. Matsuzawa, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8, 731–737 (2002)PubMed
116.
W. Pan, H. Tu, A.J. Kastin, Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 27, 911–916 (2006)PubMed
117.
J. Spranger, S. Verma, I. Göhring, T. Bobbert, J. Seifert, A.L. Sindler, A. Pfeiffer, S.M. Hileman, M. Tschöp, W.A. Banks, Adiponectin does not cross the blood–brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 55, 141–147 (2006)PubMed
118.
Y. Qi, N. Takahashi, S.M. Hileman, H.R. Patel, A.H. Berg, U.B. Pajvani, P.E. Scherer, R.S. Ahima, Adiponectin acts in the brain to decrease body weight. Nat. Med. 10, 524–529 (2004)PubMed
119.
C.M. Kusminski, P.G. McTernan, T. Schraw, K. Kos, J.P. O’Hare, R. Ahima, S. Kumar, P.E. Scherer, Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia 50, 634–642 (2007)PubMed
120.
X.-B. Cheng, J.-P. Wen, J. Yang, Y. Yang, G. Ning, X.-Y. Li, GnRH secretion is inhibited by adiponectin through activation of AMP-activated protein kinase and extracellular signal-regulated kinase. Endocrine 39, 6–12 (2011)PubMed
121.
J.-P. Wen, C. Liu, W.-K. Bi, Y.-T. Hu, Q. Chen, H. Huang, J.-X. Liang, L.-T. Li, L.-X. Lin, G. Chen, Adiponectin inhibits KISS1 gene transcription through AMPK and specificity protein-1 in the hypothalamic GT1-7 neurons. J. Endocrinol. 214, 177–189 (2012)PubMed
122.
M. Lu, Q. Tang, J.M. Olefsky, P.L. Mellon, N.J.G. Webster, Adiponectin activates adenosine monophosphate-activated protein kinase and decreases luteinizing hormone secretion in LbetaT2 gonadotropes. Mol. Endocrinol. Baltim. Md. 22, 760–771 (2008)
123.
O.M. Ocón-Grove, S.M. Krzysik-Walker, S.R. Maddineni, G.L. Hendricks 3rd, R. Ramachandran, Adiponectin and its receptors are expressed in the chicken testis: influence of sexual maturation on testicular ADIPOR1 and ADIPOR2 mRNA abundance. Reprod. Camb. Engl. 136, 627–638 (2008)
124.
A. Pfaehler, M.K. Nanjappa, E.S. Coleman, M. Mansour, D. Wanders, E.P. Plaisance, R.L. Judd, B.T. Akingbemi, Regulation of adiponectin secretion by soy isoflavones has implication for endocrine function of the testis. Toxicol. Lett. 209, 78–85 (2012)PubMed
125.
J.E. Caminos, R. Nogueiras, R. Gallego, S. Bravo, S. Tovar, T. García-Caballero, F.F. Casanueva, C. Diéguez, Expression and regulation of adiponectin and receptor in human and rat placenta. J. Clin. Endocrinol. Metab. 90, 4276–4286 (2005)PubMed
126.
P. Li, F. Sun, H.-M. Cao, Q.-Y. Ma, C.-M. Pan, J.-H. Ma, X.-N. Zhang, H. Jiang, H.-D. Song, M.-D. Chen, Expression of adiponectin receptors in mouse adrenal glands and the adrenocortical Y-1 cell line: adiponectin regulates steroidogenesis. Biochem. Biophys. Res. Commun. 390, 1208–1213 (2009)PubMed
127.
K.A. Toulis, D.G. Goulis, D. Farmakiotis, N.A. Georgopoulos, I. Katsikis, B.C. Tarlatzis, I. Papadimas, D. Panidis, Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum. Reprod. Updat. 15, 297–307 (2009)
128.
M. Otani, M. Kogo, S. Furukawa, S. Wakisaka, T. Maeda, The adiponectin paralog C1q/TNF-related protein 3 (CTRP3) stimulates testosterone production through the cAMP/PKA signaling pathway. Cytokine 58, 238–244 (2012)PubMed
129.
D.V. Lagaly, P.Y. Aad, J.A. Grado-Ahuir, L.B. Hulsey, L.J. Spicer, Role of adiponectin in regulating ovarian theca and granulosa cell function. Mol. Cell. Endocrinol. 284, 38–45 (2008)PubMed
130.
C. Chabrolle, L. Tosca, C. Ramé, P. Lecomte, D. Royère, J. Dupont, Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells. Fertil. Steril. 92, 1988–1996 (2009)PubMed
131.
J.S. Richards, Z. Liu, T. Kawai, K. Tabata, H. Watanabe, D. Suresh, F.-T. Kuo, M.D. Pisarska, M. Shimada, Adiponectin and its receptors modulate granulosa cell and cumulus cell functions, fertility, and early embryo development in the mouse and human. Fertil. Steril. 98, 471–479 (2012)PubMedCentralPubMed
132.
M.-C.M. Shih, Y.-N. Chiu, M.-C. Hu, I.-C. Guo, B. Chung, Regulation of steroid production: analysis of Cyp11a1 promoter. Mol. Cell. Endocrinol. 336, 80–84 (2011)PubMed
133.
P. Pena, A.T. Reutens, C. Albanese, M. D’Amico, G. Watanabe, A. Donner, I.W. Shu, T. Williams, R.G. Pestell, Activator protein-2 mediates transcriptional activation of the CYP11A1 gene by interaction with Sp1 rather than binding to DNA. Mol. Endocrinol. Baltim. Md. 13, 1402–1416 (1999)
134.
T. Sugawara, M. Saito, S. Fujimoto, Sp1 and SF-1 interact and cooperate in the regulation of human steroidogenic acute regulatory protein gene expression. Endocrinology 141, 2895–2903 (2000)PubMed
135.
K. Momoi, M.R. Waterman, E.R. Simpson, U.M. Zanger, 3′,5′-Cyclic adenosine monophosphate-dependent transcription of the CYP11A (cholesterol side chain cleavage cytochrome P450) gene involves a DNA response element containing a putative binding site for transcription factor Sp1. Mol. Endocrinol. Baltim. Md. 6, 1682–1690 (1992)
136.
H. Lin, C.-H. Yu, C.-Y. Jen, C.-F. Cheng, Y. Chou, C–.C. Chang, S.-H. Juan, Adiponectin-mediated heme oxygenase-1 induction protects against iron-induced liver injury via a PPARα dependent mechanism. Am. J. Pathol. 177, 1697–1709 (2010)PubMedCentralPubMed
137.
L.-F. Liu, W.-J. Shen, Z.H. Zhang, L.J. Wang, F.B. Kraemer, Adipocytes decrease Runx2 expression in osteoblastic cells: roles of PPARγ and adiponectin. J. Cell. Physiol. 225, 837–845 (2010)PubMed
138.
F.-P. Lee, C.-Y. Jen, C–.C. Chang, Y. Chou, H. Lin, C.-M. Chou, S.-H. Juan, Mechanisms of adiponectin-mediated COX-2 induction and protection against iron injury in mouse hepatocytes. J. Cell. Physiol. 224, 837–847 (2010)PubMed
139.
L. Wu, B. Xu, W. Fan, X. Zhu, G. Wang, A. Zhang, Adiponectin protects Leydig cells against proinflammatory cytokines by suppressing the nuclear factor-κB signaling pathway. FEBS J. 280, 3920–3927 (2013)PubMed
140.
C.Y. Hong, J.H. Park, R.S. Ahn, S.Y. Im, H.-S. Choi, J. Soh, S.H. Mellon, K. Lee, Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha. Mol. Cell. Biol. 24, 2593–2604 (2004)PubMedCentralPubMed
141.
C.D.B. Fernandez, F.F. Bellentani, G.S.A. Fernandes, J.E. Perobelli, A.P.A. Favareto, A.F. Nascimento, A.C. Cicogna, W.D.G. Kempinas, Diet-induced obesity in rats leads to a decrease in sperm motility. Reprod. Biol. Endocrinol. 9, 32 (2011)PubMedCentralPubMed
142.
F. Erdemir, D. Atilgan, F. Markoc, O. Boztepe, B. Suha-Parlaktas, S. Sahin, The effect of diet induced obesity on testicular tissue and serum oxidative stress parameters. Actas Urol. Españolas. 36, 153–159 (2012)
143.
Thomas, S., Kratzsch, D., Schaab, M., Scholz, M., Grunewald, S., Thiery, J., Paasch, U., Kratzsch, J.: Seminal plasma adipokine levels are correlated with functional characteristics of spermatozoa. Fertil. Steril. 99, 1256–1263 (2013)
144.
Kasimanickam, V.R., Kasimanickam, R.K., Kastelic, J.P., Stevenson, J.S.: Associations of adiponectin and fertility estimates in Holstein bulls. Theriogenology 79, 766–777 (2013)
145.
F. Rahmanifar, M.R. Tabandeh, Adiponectin and its receptors gene expression in the reproductive tract of ram. Small Rumin. Res. 105, 263–267 (2012)
146.
M.H. Dai, T. Xia, G.D. Zhang, X.D. Chen, L. Gan, S.Q. Feng, H. Qiu, Y. Peng, Z.Q. Yang, Cloning, expression and chromosome localization of porcine adiponectin and adiponectin receptors genes. Domest. Anim. Endocrinol. 30, 117–125 (2006)PubMed
147.
M. Archanco, J. Gómez-Ambrosi, M. Tena-Sempere, G. Frühbeck, M.A. Burrell, Expression of leptin and adiponectin in the rat oviduct. J. Histochem. Cytochem. Off. J. Histochem. Soc. 55, 1027–1037 (2007)
148.
E.R.M. Hofny, M.E. Ali, H.Z. Abdel-Hafez, E.E.-D. Kamal, E.E. Mohamed, H.G. Abd El-Azeem, T. Mostafa, Semen parameters and hormonal profile in obese fertile and infertile males. Fertil. Steril. 94, 581–584 (2010)PubMed
149.
150.
R. Pasquali, L. Patton, A. Gambineri, Obesity and infertility. Curr. Opin. Endocrinol. Diabetes Obes. 14, 482–487 (2007)PubMed
151.
R. Ramachandran, S. Maddineni, O. Ocón-Grove, G. Hendricks 3rd, R. Vasilatos-Younken, J.A. Hadley, Expression of adiponectin and its receptors in avian species. Gen. Comp. Endocrinol. 190, 88–95 (2013)PubMed
152.
C. Lee, C.-H. Huang, LASAGNA-Search: an integrated web tool for transcription factor binding site search and visualization. Biotechniques 54, 141–153 (2013)PubMed
153.
E. Wingender, P. Dietze, H. Karas, R. Knüppel, TRANSFAC: a database on transcription factors and their DNA binding sites. Nucl. Acids Res. 24, 238–241 (1996)PubMedCentralPubMed
Metadata
Title
Implications of adiponectin in linking metabolism to testicular function
Author
Luc J. Martin
Publication date
01-05-2014
Publisher
Springer US
Published in
Endocrine / Issue 1/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0102-0

Other articles of this Issue 1/2014

Endocrine 1/2014 Go to the issue

Original Article

Intranuclear cytoplasmic inclusions in cytologically suspicious or malignant thyroid nodules: identification and correlation with echogenicity and size of the nodules

original article

Enhanced delivery of human growth hormone across cell membrane by Tat-PTD

Original Article

Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy

Review

Epicardial adipose tissue in endocrine and metabolic diseases

Meta-Analysis

Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis

Original Article

Obesity modifies expression profiles of metabolic markers in superficial and deep subcutaneous abdominal adipose tissue depots
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits